Literature DB >> 24173213

The cellular peptidyl-prolyl cis/trans isomerase Pin1 regulates reactivation of Kaposi's sarcoma-associated herpesvirus from latency.

Jonathan Guito1, Aileen Gavina, Diana Palmeri, David M Lukac.   

Abstract

Kaposi's sarcoma-associated herpesvirus (KSHV) causes Kaposi's sarcoma and primary effusion lymphoma. KSHV-infected cells are predominantly latent, with a subset undergoing lytic reactivation. Rta is the essential lytic switch protein that reactivates virus by forming transactivation-competent complexes with the Notch effector protein RBP-Jk and promoter DNA. Strikingly, Rta homolog analysis reveals that prolines constitute 17% of conserved residues. Rta is also highly phosphorylated in vivo. We previously demonstrated that proline content determines Rta homotetramerization and function. We hypothesize that proline-directed modifications regulate Rta function by controlling binding to peptidyl-prolyl cis/trans isomerases (PPIases). Cellular PPIase Pin1 binds specifically to phosphoserine- or phosphothreonine-proline (pS/T-P) motifs in target proteins. Pin1 dysregulation is implicated in myriad human cancers and can be subverted by viruses. Our data show that KSHV Rta protein contains potential pS/T-P motifs and binds directly to Pin1. Rta transactivation is enhanced by Pin1 at two delayed early viral promoters in uninfected cells. Pin1's effect, however, suggests a rheostat-like influence on Rta function. We show that in infected cells, endogenous Pin1 is active during reactivation and enhances Rta-dependent early protein expression induced by multiple signals, as well as DNA replication. Surprisingly, ablation of Pin1 activity by the chemical juglone or dominant-negative Pin1 enhanced late gene expression and production of infectious virus, while ectopic Pin1 showed inhibitory effects. Our data thus suggest that Pin1 is a unique, dose-dependent molecular timer that enhances Rta protein function, but inhibits late gene synthesis and virion production, during KSHV lytic reactivation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24173213      PMCID: PMC3911720          DOI: 10.1128/JVI.02877-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  69 in total

1.  Promoter- and cell-specific transcriptional transactivation by the Kaposi's sarcoma-associated herpesvirus ORF57/Mta protein.

Authors:  Diana Palmeri; Sophia Spadavecchia; Kyla Driscoll Carroll; David M Lukac
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

2.  Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8).

Authors:  J J Russo; R A Bohenzky; M C Chien; J Chen; M Yan; D Maddalena; J P Parry; D Peruzzi; I S Edelman; Y Chang; P S Moore
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

Review 3.  Kaposi's sarcoma in sub-Saharan Africa: a current perspective.

Authors:  A Mosam; J Aboobaker; F Shaik
Journal:  Curr Opin Infect Dis       Date:  2010-04       Impact factor: 4.915

Review 4.  Phosphorylation-specific prolyl isomerization: is there an underlying theme?

Authors:  Gerburg Wulf; Greg Finn; Futoshi Suizu; Kun Ping Lu
Journal:  Nat Cell Biol       Date:  2005-05       Impact factor: 28.824

5.  Role of Pin1 in the regulation of p53 stability and p21 transactivation, and cell cycle checkpoints in response to DNA damage.

Authors:  Gerburg M Wulf; Yih-Cherng Liou; Akihide Ryo; Sam W Lee; Kun Ping Lu
Journal:  J Biol Chem       Date:  2002-10-17       Impact factor: 5.157

6.  Prolyl isomerization as a molecular timer in phage infection.

Authors:  Barbara Eckert; Andreas Martin; Jochen Balbach; Franz X Schmid
Journal:  Nat Struct Mol Biol       Date:  2005-06-05       Impact factor: 15.369

Review 7.  Peptidyl-prolyl cis-trans isomerase Pin1 in ageing, cancer and Alzheimer disease.

Authors:  Tae Ho Lee; Lucia Pastorino; Kun Ping Lu
Journal:  Expert Rev Mol Med       Date:  2011-06-20       Impact factor: 5.600

8.  Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells.

Authors:  K A Staskus; W Zhong; K Gebhard; B Herndier; H Wang; R Renne; J Beneke; J Pudney; D J Anderson; D Ganem; A T Haase
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

9.  Mice lacking Pin1 develop normally, but are defective in entering cell cycle from G(0) arrest.

Authors:  F Fujimori; K Takahashi; C Uchida; T Uchida
Journal:  Biochem Biophys Res Commun       Date:  1999-11-30       Impact factor: 3.575

10.  Prevalent overexpression of prolyl isomerase Pin1 in human cancers.

Authors:  Lere Bao; Amy Kimzey; Guido Sauter; Janusz M Sowadski; Kun Ping Lu; Da-Gong Wang
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

View more
  11 in total

1.  Genome-Wide Identification of Direct RTA Targets Reveals Key Host Factors for Kaposi's Sarcoma-Associated Herpesvirus Lytic Reactivation.

Authors:  Bernadett Papp; Naeem Motlagh; Richard J Smindak; Seung Jin Jang; Aria Sharma; Juan D Alonso; Zsolt Toth
Journal:  J Virol       Date:  2019-02-19       Impact factor: 5.103

2.  A herpesvirus transactivator and cellular POU proteins extensively regulate DNA binding of the host Notch signaling protein RBP-Jκ to the virus genome.

Authors:  Olga Gonzalez-Lopez; Jennifer DeCotiis; Corey Goyeneche; Helena Mello; Bryan Alexis Vicente-Ortiz; Hye Jin Shin; Kyla E Driscoll; Peicheng Du; Diana Palmeri; David M Lukac
Journal:  J Biol Chem       Date:  2019-07-15       Impact factor: 5.157

3.  Nuclear Innate Immune DNA Sensor IFI16 Is Degraded during Lytic Reactivation of Kaposi's Sarcoma-Associated Herpesvirus (KSHV): Role of IFI16 in Maintenance of KSHV Latency.

Authors:  Arunava Roy; Dipanjan Dutta; Jawed Iqbal; Gina Pisano; Olsi Gjyshi; Mairaj Ahmed Ansari; Binod Kumar; Bala Chandran
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

Review 4.  The isomerase PIN1 controls numerous cancer-driving pathways and is a unique drug target.

Authors:  Xiao Zhen Zhou; Kun Ping Lu
Journal:  Nat Rev Cancer       Date:  2016-06-03       Impact factor: 60.716

Review 5.  KSHV reactivation and novel implications of protein isomerization on lytic switch control.

Authors:  Jonathan Guito; David M Lukac
Journal:  Viruses       Date:  2015-01-12       Impact factor: 5.048

Review 6.  Molecular biology of KSHV lytic reactivation.

Authors:  Pravinkumar Purushothaman; Timsy Uppal; Subhash C Verma
Journal:  Viruses       Date:  2015-01-14       Impact factor: 5.048

Review 7.  Reactivation and Lytic Replication of Kaposi's Sarcoma-Associated Herpesvirus: An Update.

Authors:  Kawalpreet K Aneja; Yan Yuan
Journal:  Front Microbiol       Date:  2017-04-20       Impact factor: 5.640

Review 8.  Viruses and Skin Cancer.

Authors:  Sara Becerril; Roberto Corchado-Cobos; Natalia García-Sancha; Leonor Revelles; David Revilla; Tatiana Ugalde; Concepción Román-Curto; Jesús Pérez-Losada; Javier Cañueto
Journal:  Int J Mol Sci       Date:  2021-05-20       Impact factor: 5.923

9.  Overexpression of PIN1 Enhances Cancer Growth and Aggressiveness with Cyclin D1 Induction in EBV-Associated Nasopharyngeal Carcinoma.

Authors:  Meng Xu; Chartia Ching-Mei Cheung; Chit Chow; Samantha Wei-Man Lun; Siu-Tim Cheung; Kwok-Wai Lo
Journal:  PLoS One       Date:  2016-06-03       Impact factor: 3.240

10.  Functional PIN1 promoter polymorphisms associated with risk of nasopharyngeal carcinoma in Southern Chinese populations.

Authors:  Liuyan Zeng; Shengqun Luo; Xin Li; Mengxuan Lu; Huahui Li; Tong Li; Guanhua Wang; Xiaoming Lyu; Wenrui Jia; Zigang Dong; Qiang Jiang; Zhihua Shen; Guo-Liang Huang; Zhiwei He
Journal:  Sci Rep       Date:  2017-07-04       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.